Help Beverly Access Life-Saving Immunotherapy

$21,271 of $62,708 goal
Given by 29 generous donors in 20 days

Support Beverly in Her Fight Against Triple Negative Breast Cancer 🎗️🩷

Ellerslie, Auckland

Beverly Di Mercurio, 26, was diagnosed with Stage 3 Triple Negative Breast Cancer (TNBC) in March 2025 — one of the most aggressive and fast-growing forms of breast cancer.

She is currently undergoing six months of aggressive chemotherapy, doing everything she can to fight for her life. But with TNBC, chemotherapy often isn’t enough. Even after treatment, the risk of the cancer coming back remains high.

There is hope — Keytruda, a type of immunotherapy, has been shown to reduce the risk of recurrence by up to 30% and improve survival rates. But here in New Zealand, it’s only publicly funded for advanced or metastatic cancers.

Because Beverly’s cancer hasn’t spread yet, we’re left to cover the full treatment cost ourselves: $62,708 NZD.

This is an overwhelming amount, especially while also dealing with lost income, travel costs, and other cancer-related expenses.

Every donation, no matter how small, helps give Beverly a real shot at life beyond cancer.

Your kindness and aroha could be the reason she gets the treatment she needs — to achieve her dream of growing old and staying with the people who love her.

We thank you from the bottom of our hearts for standing with us in this fight. 🙏

Use of funds

Funding 1 year of immunotherapy (Pembrolizumab, also known as “Keytruda”).

Read more

Latest donations

Charmaine Violet
Charmaine Violet 3 hours ago
$80
Charmaine Violet
Charmaine Violet 3 hours ago
$20
Walter
Walter 3 hours ago
$20
Amanda
Amanda 4 hours ago
Private
Sue
Sue 5 hours ago
$20

Who's involved?

Beverly Di Mercurio's avatar
Created by, and paying to a verified bank account of, Beverly Di Mercurio
Page Moderated
The page has been checked by our team to make sure it complies with our terms and conditions.

Help Fundraise

You can create your own page to help fundraise for this cause.

Any concerns?

Report this page
This campaign started on 8 Apr 2025 and ends on 8 Apr 2026.